WeGovy is typically used in combination with a reduced-calorie diet and regular physical activity. It is typically prescribed to people with a body mass index (BMI) of 27 or higher, with exceptions for people with certain medical conditions such as diabetes or high blood pressure.
Do not use WeGovy if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy®.
Before using Wegovy, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys.
- have type 2 diabetes and a history of diabetic retinopathy.
- have or have had depression, suicidal thoughts, or mental health issues.
- are pregnant or plan to become pregnant. Wegovy may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant.
- are breastfeeding or plan to breastfeed.
The recommended dosage of Wegovy is 2.4mg injected once weekly. If you are unable to tolerate the 2.4mg weekly dosage, the dosage may be reduced to 1.7 mg once weekly. The medication will likely be discontinued if you cannot tolerate the 1.7 mg dose.
Each 1 mL of Wegovy contains the following inactive ingredients: disodium phosphate dihydrate, 1.42 mg; sodium chloride, 8.25 mg; and water for injection. Wegovy has a pH of approximately 7.4. Hydrochloric acid or sodium hydroxide may be added to adjust pH.
Side effects of WeGovy are:
- stomach (abdomen) pain
- tiredness (fatigue)
- upset stomach
- feeling bloated
- stomach flu